MULTIMETHOD CANCER OUTCOMES RESEARCH SHARED RESOURCE PROJECT SUMMARY/ABSTRACT The Multimethod Cancer Outcomes Research Shared Resource (Cancer Outcomes SR) is an essential asset to Case Comprehensive Cancer Center (Case CCC) members' research, illustrated by the breadth of scientific program involvement and reflected in the number of investigators who use this SR. Last year alone, 25 investigators, 88% of whom were Case CCC members, from 5 out of the 7 Case CCC programs used the SR. The Cancer Outcomes SR helps researchers address complex, multifactorial challenges in cancer prevention or control that require a connected, multimethod approach. The Cancer Outcomes SR connects people, organizations, and data to advance cancer research across the spectrum: discovery to intervention development, implementation, dissemination, and outcome evaluation. The Cancer Outcomes SR invests in developing deep partnerships with community organizations, large database infrastructure, and methodological expertise that integrates quantitative and qualitative methods to support complex systems modeling and multilevel interventions to improve cancer outcomes.
The Specific Aims of the Cancer Outcomes SR are to: 1. Cultivate rich community partnerships, data infrastructures, and methodological expertise to enable the conduct of relevant cancer-focused research. 2. Ground cancer research in understanding of cancer risk factors, co-morbidities, social determinants of health, behavioral measurement, and intervention opportunities. 3. Connect diverse methods and partners to support observational and intervention research on complex cancer control problems. At last review, the Cancer Outcomes SR was rated Outstanding to Excellent merit. Throughout the current funding cycle (2012-2016), the Cancer Outcomes SR provided services to 104 registered users, 29 (28%) of whom are Case CCC members, representing 5 out of the 7 Case CCC programs.
The aims of the Cancer Outcomes SR are accomplished by: Developing collaborations with diverse community research partners that transcend individual projects; Providing expertise in behavioral & outcome measurement; Integrating quantitative and qualitative methods; Supporting multilevel intervention design; Linking and analyzing public health and health care system databases; and Supporting simulation modeling. The Cancer Outcomes SR is actively expanding its population health data infrastructure to support novel research and to accelerate the integration of neighborhood- and community-based contextual data for investigators with cohort studies conducting catchment area relevant research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA043703-30
Application #
9904145
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
30
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Augestad, Knut M; Keller, Deborah S; Bakaki, Paul M et al. (2018) The impact of rectal cancer tumor height on recurrence rates and metastatic location: A competing risk analysis of a national database. Cancer Epidemiol 53:56-64
Chen, Lechuang; Feng, Zhimin; Yue, Hong et al. (2018) Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA. Nat Commun 9:4585
Patel, Rutulkumar; Zhang, Luchang; Desai, Amar et al. (2018) Mlh1 deficiency increases the risk of hematopoietic malignancy after simulated space radiation exposure. Leukemia :
Lager, Angela M; Corradin, Olivia G; Cregg, Jared M et al. (2018) Rapid functional genetics of the oligodendrocyte lineage using pluripotent stem cells. Nat Commun 9:3708
Patel, Rutulkumar; Qing, Yulan; Kennedy, Lucy et al. (2018) MMR Deficiency Does Not Sensitize or Compromise the Function of Hematopoietic Stem Cells to Low and High LET Radiation. Stem Cells Transl Med 7:513-520
Desai, Amar; Zhang, Yongyou; Park, Youngsoo et al. (2018) A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support. Haematologica 103:1054-1064
Cummings III, Kenneth C; Zimmerman, Nicole M; Maheshwari, Kamal et al. (2018) Epidural compared with non-epidural analgesia and cardiopulmonary complications after colectomy: A retrospective cohort study of 20,880 patients using a national quality database. J Clin Anesth 47:12-18
Thiagarajan, Praveena S; Sinyuk, Maksim; Turaga, Soumya M et al. (2018) Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase. Nat Commun 9:578
Qiu, Zhaojun; Oleinick, Nancy L; Zhang, Junran (2018) ATR/CHK1 inhibitors and cancer therapy. Radiother Oncol 126:450-464
Elitt, Matthew S; Shick, H Elizabeth; Madhavan, Mayur et al. (2018) Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease. Stem Cell Reports 11:711-726

Showing the most recent 10 out of 1227 publications